Indictment in scheme to divert and counterfeit HIV drugs; SEC charges former Pfizer statistician with insider trading

Taking stock of the drug industry, from the lab to the medicine chest

June 29, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Drug wholesaler owner indicted for alleged role in diverting Gilead and J&J HIV medicines Steven Diamantstein, the owner of a pharmaceutical wholesaler, has been indicted for his alleged role in distributing misbranded HIV pills. By Ed Silverman STAT+ | SEC charges former Pfizer statistician with insider trading over Paxlovid clinical trial results The SEC says Amit Dagar, who was a senior statistical program lead for the Paxlovid trial, traded Pfizer stock before results became public. By Ed Silverman STAT+ | BioMarin wins approval for gene therapy to treat hemophilia A A U.S. price has not been disclosed. In Europe, Roctavian is priced at €1.5 million, or roughly $1.6 million. By Adam Feuerstein Mark Lennihan/AP STAT+ | Alkermes shareholders re-elect directors, rebuffing effort by hedge fund Sarissa At the company's annual meeting, shareholders voted in favor of Alkermes' proposal to retain all seven of the director nominees to the board. By Adam Feuerstein and Damian Garde We have a cure for hepatitis C — so why aren't more people getting treatment? Only 1 out of 3 adults diagnosed with hepatitis C have been cured since 2013, when highly effective drugs became available in the U.S. By Abdullahi Tsanni Listen: Novavax's CEO promises a turnaround & how Lilly roiled the obesity market This episode, the new Novavax CEO discusses his plan to right the ship at a company that has struggled to make the most of its Covid vaccine. By Damian Garde and Meg Tirrell and Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser